Intellective Bio

company

About

Intellective Bio is a CDMO focusing on biopharmaceutical process development and large-scale production.

  • 11 - 50

Details

Last Funding Type
Series C
Last Funding Money Raised
¥500M
Industries
Biopharma,Biotechnology,Medical,Pharmaceutical
Founded date
Jan 1, 2018
Number Of Employee
11 - 50
Operating Status
Active

Intellectual Bio specializes in the fields of biopharmaceutical development, commercial production, and Biologics Development. IntellectiveBio is equipped with technical platforms including Protein Science, Cell Engineering, Cell Culture, Protein Purification, Analytical Science, Formulation Development

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
¥500M
Intellective Bio has raised a total of ¥500M in funding over 2 rounds. Their latest funding was raised on Aug 5, 2022 from a Series C round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Aug 5, 2022 Series C ¥500M 1 Gaorong Capital Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Intellective Bio is funded by 1 investors. Gaorong Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Gaorong Capital Yes Series C